Primary care physician treatment of low HDL: Rational approach or Pandora's Box?

Mark A. Deeg, Sindhu Jacob, Jianzhao Shen, David Marrero

Research output: Contribution to journalArticle

Abstract

Background: Guidelines for treating high low-density lipoproteins are clear, whereas guidelines for treating low high-density lipoproteins (HDL) are less so. Physicians approach to treating low HDL cholesterol is not known. Objective: To determine primary care physicians approach to managing low HDL. Methods: Three-thousand, nine-hundred and nineteen surveys were mailed to all primary care physicians in the State of Indiana, asking questions regarding demographics, case studies to assess the provider's approach to managing low HDL, and direct questions regarding management of HDL levels and general lipid knowledge questions. Results: Seven-hundred and eighty-one surveys were returned, for a response rate of 19.9%. Fifty-eight percent of participants would initiate HDL-raising therapy after achieving the appropriate low-density lipoprotein cholesterol goal. The approaches used to raise HDL included lifestyle changes (diet, exercise, smoking cessation) (85%), niacin (83%), fibric acid derivative (61%), and alcohol (31%). Reasons inhibiting initiating therapy for raising HDL included concern over side effects (56%), perceived lack of effectiveness of currently available drugs (24%), lack of clear guidelines (22%), and lack of evidenced-based trials demonstrating benefit of raising HDL (14%). For men, 40% of physicians use 40 mg/dL as a cutoff for initiating HDL-raising therapy, while 25% using a cutoff of 35 mg/dL. For women, 24% use a cutoff of 50 mg/dL for initiating HDL-raising therapy, while 12% use 45 mg/dL as a cutoff. Conclusions: The majority of primary care physicians in the State of Indiana treated low HDL with appropriate approaches, although use of alcohol to raise HDL raises concerns.

Original languageEnglish
Pages (from-to)198-202
Number of pages5
JournalJournal of Clinical Lipidology
Volume1
Issue number3
DOIs
StatePublished - Jul 2007

Fingerprint

Primary Care Physicians
HDL Lipoproteins
LDL Lipoproteins
Therapeutics
Guidelines
LDL Cholesterol
Alcohols
Physicians
Fibric Acids
Niacin
Smoking Cessation
HDL Cholesterol
Life Style
Demography
Exercise

Keywords

  • HDL
  • Primary care
  • Survey
  • Treatment patterns

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

Primary care physician treatment of low HDL : Rational approach or Pandora's Box? / Deeg, Mark A.; Jacob, Sindhu; Shen, Jianzhao; Marrero, David.

In: Journal of Clinical Lipidology, Vol. 1, No. 3, 07.2007, p. 198-202.

Research output: Contribution to journalArticle

Deeg, Mark A. ; Jacob, Sindhu ; Shen, Jianzhao ; Marrero, David. / Primary care physician treatment of low HDL : Rational approach or Pandora's Box?. In: Journal of Clinical Lipidology. 2007 ; Vol. 1, No. 3. pp. 198-202.
@article{f313e9a95341487cbd07b8c867683a1b,
title = "Primary care physician treatment of low HDL: Rational approach or Pandora's Box?",
abstract = "Background: Guidelines for treating high low-density lipoproteins are clear, whereas guidelines for treating low high-density lipoproteins (HDL) are less so. Physicians approach to treating low HDL cholesterol is not known. Objective: To determine primary care physicians approach to managing low HDL. Methods: Three-thousand, nine-hundred and nineteen surveys were mailed to all primary care physicians in the State of Indiana, asking questions regarding demographics, case studies to assess the provider's approach to managing low HDL, and direct questions regarding management of HDL levels and general lipid knowledge questions. Results: Seven-hundred and eighty-one surveys were returned, for a response rate of 19.9{\%}. Fifty-eight percent of participants would initiate HDL-raising therapy after achieving the appropriate low-density lipoprotein cholesterol goal. The approaches used to raise HDL included lifestyle changes (diet, exercise, smoking cessation) (85{\%}), niacin (83{\%}), fibric acid derivative (61{\%}), and alcohol (31{\%}). Reasons inhibiting initiating therapy for raising HDL included concern over side effects (56{\%}), perceived lack of effectiveness of currently available drugs (24{\%}), lack of clear guidelines (22{\%}), and lack of evidenced-based trials demonstrating benefit of raising HDL (14{\%}). For men, 40{\%} of physicians use 40 mg/dL as a cutoff for initiating HDL-raising therapy, while 25{\%} using a cutoff of 35 mg/dL. For women, 24{\%} use a cutoff of 50 mg/dL for initiating HDL-raising therapy, while 12{\%} use 45 mg/dL as a cutoff. Conclusions: The majority of primary care physicians in the State of Indiana treated low HDL with appropriate approaches, although use of alcohol to raise HDL raises concerns.",
keywords = "HDL, Primary care, Survey, Treatment patterns",
author = "Deeg, {Mark A.} and Sindhu Jacob and Jianzhao Shen and David Marrero",
year = "2007",
month = "7",
doi = "10.1016/j.jacl.2007.04.002",
language = "English",
volume = "1",
pages = "198--202",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Primary care physician treatment of low HDL

T2 - Rational approach or Pandora's Box?

AU - Deeg, Mark A.

AU - Jacob, Sindhu

AU - Shen, Jianzhao

AU - Marrero, David

PY - 2007/7

Y1 - 2007/7

N2 - Background: Guidelines for treating high low-density lipoproteins are clear, whereas guidelines for treating low high-density lipoproteins (HDL) are less so. Physicians approach to treating low HDL cholesterol is not known. Objective: To determine primary care physicians approach to managing low HDL. Methods: Three-thousand, nine-hundred and nineteen surveys were mailed to all primary care physicians in the State of Indiana, asking questions regarding demographics, case studies to assess the provider's approach to managing low HDL, and direct questions regarding management of HDL levels and general lipid knowledge questions. Results: Seven-hundred and eighty-one surveys were returned, for a response rate of 19.9%. Fifty-eight percent of participants would initiate HDL-raising therapy after achieving the appropriate low-density lipoprotein cholesterol goal. The approaches used to raise HDL included lifestyle changes (diet, exercise, smoking cessation) (85%), niacin (83%), fibric acid derivative (61%), and alcohol (31%). Reasons inhibiting initiating therapy for raising HDL included concern over side effects (56%), perceived lack of effectiveness of currently available drugs (24%), lack of clear guidelines (22%), and lack of evidenced-based trials demonstrating benefit of raising HDL (14%). For men, 40% of physicians use 40 mg/dL as a cutoff for initiating HDL-raising therapy, while 25% using a cutoff of 35 mg/dL. For women, 24% use a cutoff of 50 mg/dL for initiating HDL-raising therapy, while 12% use 45 mg/dL as a cutoff. Conclusions: The majority of primary care physicians in the State of Indiana treated low HDL with appropriate approaches, although use of alcohol to raise HDL raises concerns.

AB - Background: Guidelines for treating high low-density lipoproteins are clear, whereas guidelines for treating low high-density lipoproteins (HDL) are less so. Physicians approach to treating low HDL cholesterol is not known. Objective: To determine primary care physicians approach to managing low HDL. Methods: Three-thousand, nine-hundred and nineteen surveys were mailed to all primary care physicians in the State of Indiana, asking questions regarding demographics, case studies to assess the provider's approach to managing low HDL, and direct questions regarding management of HDL levels and general lipid knowledge questions. Results: Seven-hundred and eighty-one surveys were returned, for a response rate of 19.9%. Fifty-eight percent of participants would initiate HDL-raising therapy after achieving the appropriate low-density lipoprotein cholesterol goal. The approaches used to raise HDL included lifestyle changes (diet, exercise, smoking cessation) (85%), niacin (83%), fibric acid derivative (61%), and alcohol (31%). Reasons inhibiting initiating therapy for raising HDL included concern over side effects (56%), perceived lack of effectiveness of currently available drugs (24%), lack of clear guidelines (22%), and lack of evidenced-based trials demonstrating benefit of raising HDL (14%). For men, 40% of physicians use 40 mg/dL as a cutoff for initiating HDL-raising therapy, while 25% using a cutoff of 35 mg/dL. For women, 24% use a cutoff of 50 mg/dL for initiating HDL-raising therapy, while 12% use 45 mg/dL as a cutoff. Conclusions: The majority of primary care physicians in the State of Indiana treated low HDL with appropriate approaches, although use of alcohol to raise HDL raises concerns.

KW - HDL

KW - Primary care

KW - Survey

KW - Treatment patterns

UR - http://www.scopus.com/inward/record.url?scp=34447330183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447330183&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2007.04.002

DO - 10.1016/j.jacl.2007.04.002

M3 - Article

C2 - 21291682

AN - SCOPUS:34447330183

VL - 1

SP - 198

EP - 202

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 3

ER -